PDCD1 and neoplasm: With this approach, we quantify a significant impact of host genetics in modulating ICI responses across several distinct tumor models, and map distinct quantitative trait loci (QTLs) that both additively and epistatically influence response to anti-PD-1 (aPD1) immunotherapy.